blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2379079

EP2379079 - PHARMACEUTICAL FORMULATIONS COMPRISING VORICONAZOLE AND PROCESSES FOR PREPARATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.02.2018
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  10.03.2017
FormerGrant of patent is intended
Status updated on  16.11.2016
Most recent event   Tooltip29.05.2020Lapse of the patent in a contracting state
New state(s): PT		published on 01.07.2020  [2020/27]
Applicant(s)For all designated states
Nanjing Cavendish Bio-Engineering Technology Co., Ltd.
No. 6 Maiyue Road Maigaoqiao Pioneering Park Qixia District Nanjing
Jiangsu 210028 / CN
For all designated states
Xu, Yongxiang
Room 105 No 9 Yijing Garden Gulou Digest Nanjing
Jiangsu 210001 / CN
[2011/43]
Inventor(s)01 / XU, Yongxiang
Room 105
No. 9 Yijing Garden
Gulou
Nanjing
Jiangsu 210001 / CN
 [2011/43]
Representative(s)Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2011/43]Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A.
Corso di Porta Vittoria 9
20122 Milano / IT
Application number, filing date09836088.631.12.2009
[2017/15]
WO2009CN76328
Priority number, dateCN20081019298531.12.2008         Original published format: CN200810192985
[2011/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010075801
Date:08.07.2010
Language:EN
[2010/27]
Type: A1 Application with search report 
No.:EP2379079
Date:26.10.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 08.07.2010 takes the place of the publication of the European patent application.
[2011/43]
Type: B1 Patent specification 
No.:EP2379079
Date:12.04.2017
Language:EN
[2017/15]
Search report(s)International search report - published on:CN08.07.2010
(Supplementary) European search report - dispatched on:EP31.10.2013
ClassificationIPC:A61K31/506, A61K47/34, A61K9/19, A61P31/10
[2011/43]
CPC:
A61K47/34 (EP,KR,US); A61K9/19 (EP,KR,US); A61K31/4196 (KR);
A61K31/506 (EP,KR,US); A61K47/14 (EP,US); A61K9/0019 (EP,US);
A61P31/00 (EP); A61P31/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/15]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:PHARMAZEUTISCHE FORMULIERUNGEN MIT VORICONAZOL UND HERSTELLUNGSVERFAHREN DAFÜR[2011/45]
English:PHARMACEUTICAL FORMULATIONS COMPRISING VORICONAZOLE AND PROCESSES FOR PREPARATION THEREOF[2011/43]
French:FORMULES PHARMACEUTIQUES COMPRENANT DU VORICONAZOLE ET LEURS PROCÉDÉS D'ÉLABORATION[2011/43]
Former [2011/43]PHARMAZEUTISCHE FORMULIERUNGEN MIT VORICONAZOL UND HERSTELLUNGSVERFAHREN DAF?R
Entry into regional phase28.06.2011National basic fee paid 
28.06.2011Search fee paid 
28.06.2011Designation fee(s) paid 
28.06.2011Examination fee paid 
Examination procedure28.06.2011Examination requested  [2011/43]
14.05.2014Amendment by applicant (claims and/or description)
17.11.2016Communication of intention to grant the patent
03.03.2017Fee for grant paid
03.03.2017Fee for publishing/printing paid
03.03.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.11.2016
Opposition(s)15.01.2018No opposition filed within time limit [2018/12]
Fees paidRenewal fee
21.12.2011Renewal fee patent year 03
09.11.2012Renewal fee patent year 04
24.12.2013Renewal fee patent year 05
22.12.2014Renewal fee patent year 06
23.12.2015Renewal fee patent year 07
29.12.2016Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.12.2009
AT12.04.2017
CY12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
MK12.04.2017
NL12.04.2017
PL12.04.2017
PT12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
TR12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
CH31.12.2017
IE31.12.2017
LI31.12.2017
LU31.12.2017
MT31.12.2017
[2020/27]
Former [2020/15]HU31.12.2009
AT12.04.2017
CY12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
MK12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
TR12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
CH31.12.2017
IE31.12.2017
LI31.12.2017
LU31.12.2017
MT31.12.2017
Former [2019/51]HU31.12.2009
AT12.04.2017
CY12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
MK12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
CH31.12.2017
IE31.12.2017
LI31.12.2017
LU31.12.2017
MT31.12.2017
Former [2019/46]HU31.12.2009
AT12.04.2017
CY12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
CH31.12.2017
IE31.12.2017
LI31.12.2017
LU31.12.2017
MT31.12.2017
Former [2019/31]HU31.12.2009
AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
CH31.12.2017
IE31.12.2017
LI31.12.2017
LU31.12.2017
MT31.12.2017
Former [2019/30]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
MC12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
CH31.12.2017
IE31.12.2017
LI31.12.2017
LU31.12.2017
MT31.12.2017
Former [2018/52]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
CH31.12.2017
IE31.12.2017
LI31.12.2017
LU31.12.2017
MT31.12.2017
Former [2018/50]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
BE31.12.2017
IE31.12.2017
LU31.12.2017
MT31.12.2017
Former [2018/45]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
IE31.12.2017
LU31.12.2017
MT31.12.2017
Former [2018/43]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
LU31.12.2017
MT31.12.2017
Former [2018/25]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SI12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
Former [2018/11]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
IT12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SK12.04.2017
SM12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
Former [2018/10]AT12.04.2017
CZ12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
RO12.04.2017
SE12.04.2017
SK12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
Former [2018/09]AT12.04.2017
DK12.04.2017
EE12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
SE12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
Former [2017/50]AT12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
LV12.04.2017
NL12.04.2017
PL12.04.2017
SE12.04.2017
BG12.07.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
Former [2017/49]AT12.04.2017
ES12.04.2017
FI12.04.2017
HR12.04.2017
LT12.04.2017
NL12.04.2017
NO12.07.2017
GR13.07.2017
IS12.08.2017
Former [2017/48]NL12.04.2017
Documents cited:Search[Y]WO2005051353  (PFIZER LTD [GB], et al) [Y] 1-13 * page 2, line 4 - line 17 * * page 3, line 7 - line 10 * * example - * * claim - *;
 [Y]  - YI ET AL, "A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20070130), vol. 117, no. 1, doi:10.1016/J.JCONREL.2006.10.001, ISSN 0168-3659, pages 59 - 67, XP005864292 [Y] 1-13 * abstract * * page 59, column l, paragraph l - page 60, column l, paragraph 3 * * paragraphs [02.3] , [ 2.5] * * paragraph [0004] *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2006.10.001
International search[Y]WO9858677  (PFIZER LTD [GB], et al);
 [Y]CN1813751  (NANJING DUYAO PHARMACEUTICAL S [CN]);
 [Y]CN1861044  (DUYAO PHARMACEUTICAL SCIENCE C [CN]);
 [XP]CN101444510  (NANJING HENRY CAVENDISH BIOENG [CN])
 [Y]  - JI, DONGYING ET AL., "Synthesis of PLA-mPEG and preparation of docetaxel polymer micelles", JOURNAL OF CHINA PHARMACEUTICAL UNIVERSITY, (20080625), vol. 39, no. 3, pages 223 - 227
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.